<- Go Home
Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products.
Market Cap
$435.6M
Volume
2.9M
Cash and Equivalents
$35.6M
EBITDA
-$196.5M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
-$61.0M
Profit Margin
-1674.48%
52 Week High
$3.73
52 Week Low
$0.92
Dividend
N/A
Price / Book Value
1.82
Price / Earnings
-1.55
Price / Tangible Book Value
2.23
Enterprise Value
$231.3M
Enterprise Value / EBITDA
-1.18
Operating Income
-$197.1M
Return on Equity
-94.81%
Return on Assets
-35.69
Cash and Short Term Investments
$310.0M
Debt
$105.7M
Equity
$240.0M
Revenue
$3.6M
Unlevered FCF
-$108.8M
Sector
Biotechnology
Category
N/A